A Study of Thymic Humoral Factor (THF Gamma 2) in HIV-Infected Patients

Summary

To investigate the safety of thymic humoral factor (THF gamma 2), its effect on HIV load based on at least a 75 percent decrease in HIV quantitative PCR RNA copies/ml, and its persistence when administered in combination with an antiretroviral nucleoside derivative (zidovudine; AZT). To assess the effects of THF gamma 2 on T-cells, quality of life, and progression of disease.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications